Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 13,008,900 | 12,161,600 | 11,863,900 | 13,136,100 | 13,978,500 |
| Cost of Goods | 9,384,500 | 8,796,700 | 8,155,000 | 8,143,700 | 9,025,700 |
| Gross Profit | 3,624,400 | 3,364,900 | 3,708,900 | 4,992,400 | 4,952,800 |
| Operating Expenses | 2,538,200 | 2,640,000 | 2,272,400 | 1,944,500 | 2,508,100 |
| Operating Income | 1,086,700 | 725,600 | 1,436,500 | 3,048,600 | 2,445,400 |
| Interest Expense | 208,300 | 199,600 | 179,800 | 211,800 | 207,400 |
| Other Income | 81,100 | 42,900 | -19,300 | 50,800 | -18,900 |
| Pre-tax Income | 959,500 | 568,900 | 1,237,400 | 2,887,600 | 2,219,100 |
| Income Tax | 212,400 | 188,500 | 233,900 | 690,000 | 662,100 |
| Net Income Continuous | 747,100 | 380,400 | 1,003,500 | 2,197,600 | 1,557,000 |
| Net Income Discontinuous | N/A | 38,800 | 277,100 | 181,900 | N/A |
| Minority Interests | 1,100 | 1,200 | 1,500 | 2,200 | 900 |
| Net Income | $746,000 | $418,000 | $1,279,100 | $2,377,300 | $1,556,100 |
| EPS Basic Total Ops | 8.89 | 4.80 | 14.05 | 24.60 | 15.99 |
| EPS Basic Continuous Ops | 8.89 | 4.35 | 11.00 | 22.71 | 16.00 |
| EPS Basic Discontinuous Ops | N/A | 0.45 | 3.04 | 1.88 | N/A |
| EPS Diluted Total Ops | 8.84 | 4.77 | 13.97 | 24.39 | 15.88 |
| EPS Diluted Continuous Ops | 8.84 | 4.33 | 10.94 | 22.52 | 15.89 |
| EPS Diluted Discontinuous Ops | N/A | 0.44 | 3.03 | 1.87 | N/A |
| EPS Diluted Before Non-Recurring Items | 14.57 | 13.56 | 19.94 | 28.52 | 23.94 |
| EBITDA(a) | $1,730,200 | $1,302,900 | $1,973,701 | $3,625,600 | $3,532,200 |